Quantcast

Latest Heavy metal Stories

2014-07-31 12:26:31

Former Korn Drummer David Silveria and Former Anyone Vocalist/Musician Riz Story Announce Release Date of INFINIKA's Debut Album "Echoes and Traces" LOS ANGELES, July 31, 2014 /PRNewswire-iReach/ -- Today, INFINIKA announced the release date for their long-awaited debut album, Echoes and Traces, with digital drop set for September 1, 2014. (Photo - http://photos.prnewswire.com/prnh/20140731/132095) Featuring former Korn drummer David Silveria and former Anyone frontman Riz Story,...

2014-07-28 08:28:42

CARLSBAD, Calif., July 28, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Isis Pharmaceuticals' Second Quarter 2014 Financial Results and Highlights Conference Call When: Monday, August 4 at 10:30 a.m. ET /7:30 a.m. PT Where: www.isispharm.com How: Live on the Internet. Simply log onto our website listed above....

2014-07-24 12:31:14

Customer satisfaction and high retention rate prove to be a testament to 25 years in business POTTSVILLE, Pa., July 24, 2014 /PRNewswire/ -- EXTOL International, a leading provider of end-to-end business integration software and services, has earned a high Net Promoter Score® of 70.15. This loyalty metric is used by companies around the world to gauge customer satisfaction, and provide visibility to areas for growth. As part of its 25(th) anniversary celebration, EXTOL engaged with...

2014-07-16 08:27:14

CARLSBAD, Calif., July 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTR(Rx) in patients with familial amyloid polyneuropathy (FAP). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO ISIS-TTR(Rx) is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare...

2014-07-15 08:35:43

POTTSVILLE, Pa., July 15, 2014 /PRNewswire/ -- EXTOL International, a leading provider of e-business integration software and services, is pleased to announce that Generac Power Systems, the world's #1 home back-up generator manufacturer, has chosen the EXTOL Business Integrator (EBI) to help support their 20% annual growth. Generac's decision to go with EXTOL's flagship B2B integration platform was due to its modern EDI and integration capabilities that include multi-syntax support...

2014-07-12 23:01:46

Living legends of heavy metal Judas Priest have announced a North American world tour that will take them to some of the biggest stages around the globe beginning in a few short days, and TicketProcess.com has important tour information and a wide selection of affordable tickets. (PRWEB) July 12, 2014 Judas Priest is one of the most instrumental and important bands in the heavy metal movement, which they themselves put into motion in the early 1980s. A few decades later, their fan base is...

2014-07-10 08:32:53

B2B integration software provider hires industry veteran to lead global sales initiative POTTSVILLE, Pa., July 10, 2014 /PRNewswire/ -- EXTOL International, a leading provider of e-business integration software and services, today announced the addition of Peter Harper to its executive leadership team as the company's vice president of sales. In his new role, Harper will lead the sales team in identifying global industry changes to best position the company's technology solutions....

2014-07-02 08:26:15

CARLSBAD, Calif., July 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million payment from GlaxoSmithKline (GSK) related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "Our collaboration with GSK has been very productive resulting in three novel antisense drugs in our pipeline. We look forward to continuing to advance...

2014-06-24 08:29:49

CARLSBAD, Calif., June 24, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTR(Rx) in patients with familial amyloid polyneuropathy (FAP). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO ISIS-TTR(Rx) is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and...

2014-06-17 08:28:25

CARLSBAD, Calif., June 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today it has earned a $10 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder. This is the first milestone payment under Isis' and Biogen Idec's 2013 strategic collaboration to advance the treatment of neurological disorders. This collaboration combines Biogen Idec's expertise in neurology with Isis'...


Latest Heavy metal Reference Libraries

Brilliant Emerald, Somatochlora metallica
2013-07-30 14:54:37

The brilliant emerald (Somatochlora metallica) is a species of dragonfly that can be found in northern areas of Eurasia. Its range includes Austria, Belgium, Croatia, Denmark, France, Germany, Norway, Serbia, Sweden, and the United Kingdom, among many other areas. This species prefers to reside near still and slow-moving water sources like rivers, canals, ponds, and moorland lakes. It is common in most areas of its range, but its total population number and population trend is unknown. It is...

More Articles (1 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related